Aspen Aerogels (NYSE:ASPN) Stock Price Passes Above 50 Day Moving Average – Here’s What Happened

Aspen Aerogels, Inc. (NYSE:ASPN) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $3.30 and traded as high as $3.54. Aspen Aerogels shares last traded at $3.4550, with a volume of 1,331,533 shares changing hands.

Analyst Upgrades and Downgrades

Several equities analysts have commented on ASPN shares. Barclays lowered their price target on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a report on Friday, November 7th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, December 29th. Canaccord Genuity Group decreased their price target on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a report on Friday, November 7th. Finally, Zacks Research downgraded Aspen Aerogels from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $12.67.

Aspen Aerogels Stock Up 2.8%

The firm’s 50-day simple moving average is $3.30 and its 200-day simple moving average is $5.88. The company has a debt-to-equity ratio of 0.28, a quick ratio of 3.33 and a current ratio of 3.94. The company has a market capitalization of $285.56 million, a price-to-earnings ratio of -0.93 and a beta of 2.94.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Thursday, November 6th. The construction company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.05). Aspen Aerogels had a negative net margin of 86.52% and a negative return on equity of 0.20%. The company had revenue of $73.02 million during the quarter, compared to the consensus estimate of $73.42 million. During the same quarter in the previous year, the business posted ($0.17) EPS. The firm’s quarterly revenue was down 37.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. Sell-side analysts forecast that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Insider Buying and Selling

In other Aspen Aerogels news, CEO Donald R. Young sold 56,845 shares of Aspen Aerogels stock in a transaction on Thursday, November 13th. The shares were sold at an average price of $3.23, for a total transaction of $183,609.35. Following the sale, the chief executive officer owned 494,011 shares in the company, valued at $1,595,655.53. The trade was a 10.32% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 3.40% of the stock is currently owned by company insiders.

Institutional Trading of Aspen Aerogels

Several institutional investors have recently made changes to their positions in the business. Royal Bank of Canada increased its stake in Aspen Aerogels by 84.7% in the first quarter. Royal Bank of Canada now owns 56,419 shares of the construction company’s stock valued at $360,000 after acquiring an additional 25,880 shares during the period. AQR Capital Management LLC bought a new stake in shares of Aspen Aerogels in the 1st quarter valued at approximately $960,000. Integrated Wealth Concepts LLC acquired a new position in shares of Aspen Aerogels in the 1st quarter worth approximately $84,000. Goldman Sachs Group Inc. lifted its position in shares of Aspen Aerogels by 89.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after buying an additional 602,586 shares during the period. Finally, Caxton Associates LLP acquired a new stake in Aspen Aerogels in the 1st quarter valued at $307,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.